GH1 and major depressive disorder: Our results indicate improvement in the CES-D score in the acromegaly patients but not in the NFPA control group and that the improvement was concordant with that of GH-level decrease, indicating some specificity in the role of GH in the etiology of depression in acromegaly patients.